Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP829275.RAVqDgT6Q0M7GLVTpLd3p_Di5TvOQ6DBHZU01dttDVroI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP829275.RAVqDgT6Q0M7GLVTpLd3p_Di5TvOQ6DBHZU01dttDVroI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP829275.RAVqDgT6Q0M7GLVTpLd3p_Di5TvOQ6DBHZU01dttDVroI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP829275.RAVqDgT6Q0M7GLVTpLd3p_Di5TvOQ6DBHZU01dttDVroI130_provenance.
- NP829275.RAVqDgT6Q0M7GLVTpLd3p_Di5TvOQ6DBHZU01dttDVroI130_assertion description "[We show in our current study that the LKB1/AMPK/TSC tumor suppressor axis is functional in AML and can be activated by the biguanide molecule metformin, resulting in a specific inhibition of mammalian target of rapamycin (mTOR) catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829275.RAVqDgT6Q0M7GLVTpLd3p_Di5TvOQ6DBHZU01dttDVroI130_provenance.
- NP829275.RAVqDgT6Q0M7GLVTpLd3p_Di5TvOQ6DBHZU01dttDVroI130_assertion evidence source_evidence_literature NP829275.RAVqDgT6Q0M7GLVTpLd3p_Di5TvOQ6DBHZU01dttDVroI130_provenance.
- NP829275.RAVqDgT6Q0M7GLVTpLd3p_Di5TvOQ6DBHZU01dttDVroI130_assertion SIO_000772 20668229 NP829275.RAVqDgT6Q0M7GLVTpLd3p_Di5TvOQ6DBHZU01dttDVroI130_provenance.
- NP829275.RAVqDgT6Q0M7GLVTpLd3p_Di5TvOQ6DBHZU01dttDVroI130_assertion wasDerivedFrom befree-2016 NP829275.RAVqDgT6Q0M7GLVTpLd3p_Di5TvOQ6DBHZU01dttDVroI130_provenance.
- NP829275.RAVqDgT6Q0M7GLVTpLd3p_Di5TvOQ6DBHZU01dttDVroI130_assertion wasGeneratedBy ECO_0000203 NP829275.RAVqDgT6Q0M7GLVTpLd3p_Di5TvOQ6DBHZU01dttDVroI130_provenance.
- befree-2016 importedOn "2016-02-19" NP829275.RAVqDgT6Q0M7GLVTpLd3p_Di5TvOQ6DBHZU01dttDVroI130_provenance.